Clinical Trial

Remimazolam NeuroImaging

Name: Remimazolam NeuroImaging — clinical trial record (NCT07290205)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REMAZ

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-15.

Trial Details

NCT Number	NCT07290205
Lead Sponsor	Keith M Vogt Collaborators: National Institute of General Medical Sciences (NIGMS)
Conditions	Anesthesia, Pain, Remimazolam
Enrollment	60 participants
Start Date	2026-03-27
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-02